Renee Simms

916 citations

17 papers · 560 indexed · h-index 11

Impact in

Epidemiology top 10%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
Oncology top 10%
- Polyomavirus and related diseases
- CAR-T cell therapy research

Papers in ⓘ

Epidemiology 12
- Cytomegalovirus and herpesvirus research 11
- Herpesvirus Infections and Treatments 7
Parasitology 2

Co-authors: David Gottlieb (16 shared papers)Emily Blyth (16 shared papers)Leighton Clancy (16 shared papers)Kenneth Micklethwaite (14 shared papers)Jane Burgess (8 shared papers)Peter J. Shaw (6 shared papers)Ming‐Celine Dubosq (2 shared papers)Shivashni Deo (3 shared papers)
Journals: Cytotherapy (5 papers)Blood (4 papers)Biology of Blood and Marrow Transplantation (3 papers)Blood Advances (2 papers)Clinical Kidney Journal (1 paper)
Partner nations: Australia United Kingdom

In The Last Decade

Renee Simms

16 papers receiving 555 citations

Peers

Countries citing papers authored by Renee Simms

Since Specialization

Citations

This map shows the geographic impact of Renee Simms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renee Simms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renee Simms more than expected).

Fields of papers citing papers by Renee Simms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renee Simms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renee Simms. The network helps show where Renee Simms may publish in the future.

Co-authors

The 25 scholars most cited alongside Renee Simms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Renee Simms Line = papers co-authored together Renee Simms links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation Blood ·Emily Blyth, Leighton Clancy, Renee Simms, K. K. Chun, Jane Burgess, Shivashni Deo, Karen Byth, Ming‐Celine Dubosq, Peter J. Shaw, Kenneth Micklethwaite, David Gottlieb	2013	181
2	Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells Blood Advances ·Barbara Withers, Emily Blyth, Leighton Clancy, Agnes S. M. Yong, Chris Fraser, Jane Burgess, Renee Simms, Rebecca T. Brown, David Kliman, Ming‐Celine Dubosq, David Bishop, Gaurav Sutrave, Chun Kei Kris, Peter J. Shaw, Kenneth Micklethwaite, David Gottlieb	2017	104
3	BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses Transplantation ·Emily Blyth, Leighton Clancy, Renee Simms, Shivashni S. Gaundar, Philip J. O’Connell, Kenneth Micklethwaite, David Gottlieb	2011	53
4	Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program Biology of Blood and Marrow Transplantation ·Barbara Withers, Leighton Clancy, Jane Burgess, Renee Simms, Rebecca T. Brown, Kenneth Micklethwaite, Emily Blyth, David Gottlieb	2018	47
5	Addition of varicella zoster virus–specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation Cytotherapy ·Chun K.K., Emily Blyth, Leighton Clancy, Renee Simms, Jane Burgess, Rebecca T. Brown, Shivashni Deo, Kenneth Micklethwaite, David Gottlieb	2015	45
6	Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor Cell Products Ex Vivo and Safely Transferred to Stem Cell Transplantation Recipients to Facilitate Immune Reconstitution Biology of Blood and Marrow Transplantation ·Leighton Clancy, Emily Blyth, Renee Simms, Kenneth Micklethwaite, K. Chun-Kei, Jane Burgess, Vicki Antonenas, Peter J. Shaw, David Gottlieb	2013	32
7	Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant Blood Advances ·Wei Jiang, Leighton Clancy, Selmir Avdic, Gaurav Sutrave, Janine Street, Renee Simms, Helen M. McGuire, Ellis Patrick, Adam S. Chan, Georgia McCaughan, Nadav Myers, Kenneth Micklethwaite, Vicki Antonenas, Adrian Selim, David Ritchie, Caroline M. Bateman, Peter J. Shaw, Emily Blyth, David Gottlieb	2022	26
8	Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients Cytotherapy ·Emily Blyth, Shivashni S. Gaundar, Leighton Clancy, Renee Simms, Ian Bilmon, Kenneth Micklethwaite, David Gottlieb	2012	22
9	In vitro generation of influenza-specific polyfunctional CD4+ T cells suitable for adoptive immunotherapy Cytotherapy ·Shivashni S. Gaundar, Emily Blyth, Leighton Clancy, Renee Simms, Chun K.K., David Gottlieb	2011	13
10	Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients Biology of Blood and Marrow Transplantation ·Chun K.K., Leighton Clancy, Renee Simms, Jane Burgess, Shivashni Deo, Emily Blyth, Kenneth Micklethwaite, David Gottlieb	2017	12
11	Matched sibling donor-derived piggybac CAR19 T cells induce remission of relapsed/refractory CD19+ malignancy following haematopoietic stem cell transplant Cytotherapy ·David Bishop, Leighton Clancy, Janette K. Burgess, Geena Mathew, Elissa Atkins, S. Advic, Karen Maddock, Janine Street, Leili Moezzi, Renee Simms, Kate Stephen, Tracey O’Brien, Peter J. Shaw, David Gottlieb, Emily Blyth, Kenneth Micklethwaite	2019	10
12	Third-Party Donor Virus-Specific T Cells Are Efficacious in the Treatment of Refractory Viral Infection Following Allogeneic HSCT, but May Not Persist Post-Infusion Blood ·Barbara Withers, Emily Blyth, Leighton Clancy, Jane Burgess, Renee Simms, Kenneth Micklethwaite, David Gottlieb	2015	6
13	Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant American Journal of Hematology ·David Gottlieb, Gaurav Sutrave, Wei Jiang, Selmir Avdic, Janine Street, Renee Simms, Leighton Clancy, Vicki Antonenas, Brian Gloss, Caroline M. Bateman, David Bishop, Kenneth Micklethwaite, Emily Blyth	2022	4
14	Administration of Third-Party Virus-Specific T-Cells (VST) at the Time of Initial Therapy for Infection after Haemopoietic Stem Cell Transplant Is Safe and Associated with Favourable Clinical Outcomes (the R3ACT-Quickly trial) Blood ·David Gottlieb, Wei Jiang, Selmir Avdic, Leighton Clancy, Gaurav Sutrave, Caroline M. Bateman, Elissa Atkins, Adrian Selim, Vicki Antonenas, David R. Collins, Janine Street, Renee Simms, Peter J. Shaw, David Ritchie, Emily Blyth	2019	3
15	Emphysematous pyelonephritis leading to end-stage renal failure Clinical Kidney Journal ·Renee Simms, N. Torpey, Nigel S. Kanagasundaram, Laura Baines, John A. Sayer	2008	1
16	Therapeutic Infusion of Partially HLA-Matched Third-Party Virus-Specific T Cells in HSCT Patients with Refractory Viral Infection Blood ·Leighton Clancy, Emily Blyth, Barbara Withers, Jane Burgess, Renee Simms, Chun Kei Kris, Kenneth Micklethwaite, David Gottlieb	2014	1
17	Allogeneic stem cell transplant (HSCT) for acute lymphoblastic leukaemia (ALL) using CD34 selected stem cells followed by prophylactic infusions of pathogen-specific and CD19 CAR T cells Cytotherapy ·Emily Blyth, Wei Jiang, Leighton Clancy, Gaurav Sutrave, Janine Street, Renee Simms, Selmir Avdic, Elissa Atkins, Vicki Antonenas, David Bishop, Kenneth Micklethwaite, David Gottlieb	2020	0

About Renee Simms

Renee Simms is a scholar working on Epidemiology, Parasitology, Immunology, Genetics and Oncology, having authored 17 papers that have together received 560 indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (11 papers), Virus-based gene therapy research (7 papers), Herpesvirus Infections and Treatments (7 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers), Polyomavirus and related diseases (2 papers), Immunotherapy and Immune Responses (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Epidemiology (412 citations), Oncology (322 citations), Hematology (77 citations), Genetics (192 citations) and Immunology (136 citations). Renee Simms has collaborated with scholars based in Australia and United Kingdom. Frequent co-authors include David Gottlieb, Emily Blyth, Leighton Clancy, Kenneth Micklethwaite, Jane Burgess, Peter J. Shaw, Ming‐Celine Dubosq, Shivashni Deo, Rebecca T. Brown and Karen Byth. Their work appears in journals such as Cytotherapy, Blood, Biology of Blood and Marrow Transplantation, Blood Advances and Clinical Kidney Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact